from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3421c/-

LFCtreatmentdescriptionclass of inhibitor

-0.568

Amikacinug/mL Amikacintranslation

-1.028

Cap5-10ug/mL Capreomycintranslation

-0.478

Rox10-50 ug/mL Roxithromycintranslation

-0.558

SM2-5 ug/mL Streptomycintranslation

0.506

Tet5-10 ug/mL Tetracyclinetranslation

-0.343

Rif0.2-5ug/mL Rifampicintranscription

-0.667

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.293

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.245

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.027

CPZ10-50 ug/mL Chlorpromazinerespiration

0.807

Clofazimine10-13 ug/mL Clofaziminerespiration

0.696

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.890

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.934

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.136

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.374

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.307

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.445

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.158

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.211

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.866

KCN5-20 ug/mL Potassium cyaniderespiration

0.131

NaN30.2-2 mM Sodium aziderespiration

-1.085

Nigericin50 uM Nigericinrespiration

-0.293

TRC10-150 ug/mL Triclosanrespiration

0.007

TRZ10-25 ug/mL Thioridazinerespiration

0.742

Valinomycin0.5-10 uM Valinomycinrespiration

-0.557

ZnSO42 mM ZnSO4respiration

-1.140

menadione6-10 ug/mL Menadionerespiration

0.174

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.331

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.163

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.276

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.429

NRP_1Non-replicating persistence stage 1dosRassociated

-0.348

Amp0.2mg/mL AmpicillincellWall

0.512

Cephalexin20-100 ug/mL CephalexincellWall

-0.547

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.431

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.141

EMB10-20 ug/mL EthambutolcellWall

-0.407

Eta12-40 ug/mL EthionamidecellWall

-0.235

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.639

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.622

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.643

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.256

BZA0.12 mg/mL BenzamidearomaticAmides

-0.282

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.023

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.074

H2O24 mM hydrogen peroxideDNAdamaging

-0.085

Levo10 ug/mL LevofloxacinDNAdamaging

-0.244

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.166

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.166

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.336

UVUV-irradiationDNAdamaging

0.444

ARP41-4 ug/mL Antitubercular compound ARP4?

0.149

Antimycin12.5-50 ug/mL Antimycin A?

-0.612

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.095

PA_110-50 ug/mL Antitubercular compound PA-1?

0.038

PA_2110-50 ug/mL Antitubercular compound PA-21?

3.000

PA8240.2-2 ug/mL PA-824?

1.499

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.120

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.796

Verapamil50 uM Verapamil?

-0.812

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.167

methoxatin10-20 ug/mL Methoxatin?